Literature DB >> 19732880

Ovarian steroid hormones differentially regulate thrombospondin-1 expression in cultured endometrial stromal cells: implications for endometriosis.

Xian-Jie Tan1, Jing-He Lang, Wei-Ming Zheng, Jin-Hua Leng, Lan Zhu.   

Abstract

Thrombospondin-1 messenger RNA and protein levels in cultured human endometrial stromal cells (ESCs) treated with 17-beta estradiol (10 nM) were reduced by 47.6% (+/-6.5% SD; P < 0.05) and 49.0% (+/-8.6%; P < 0.05) compared with untreated cells, whereas thrombospondin-1mRNA and protein levels in ESCs treated with progesterone (10 microM) were 2.1-fold (+/-0.4 SD; P < 0.05) and 2.3-fold (+/-0.6; P < 0.05) higher than those in untreated cells. These findings not only provide evidence for the estrogen dependence of endometriosis, but also partly explain the mechanisms by which progestins exert their therapeutic activities in endometriosis. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732880     DOI: 10.1016/j.fertnstert.2009.06.060

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Thrombospondin-1 in maladaptive aging responses: a concept whose time has come.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

2.  Phytochemical characteristics from Phaleria macrocarpa and its inhibitory activity on the peritoneal damage of endometriosis.

Authors:  Maharani Maharani; Lia Lajuna; Cut Yuniwati; Oktalia Sabrida; Sutrisno Sutrisno
Journal:  J Ayurveda Integr Med       Date:  2020-12-04

Review 3.  Progesterone interactions with the cervix: translational implications for term and preterm birth.

Authors:  Bryan Larsen; Joseph Hwang
Journal:  Infect Dis Obstet Gynecol       Date:  2011-10-27

4.  Decreased serum levels of thrombospondin-1 in female depressed patients.

Authors:  Mami Okada-Tsuchioka; Wataru Omori; Naoto Kajitani; Chiyo Shibasaki; Kei Itagaki; Minoru Takebayashi
Journal:  Neuropsychopharmacol Rep       Date:  2019-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.